Guest: Mark G. Martens MD, FACOG

Years ago only 5% of vaginal yeast infections were caused by non-albicans Candida. Today, an estimated 30% are caused by these species—and they’re becoming less responsive to fluconazole. This abridged version of Dr. Mark G. Marten's well-received conference presentation provides a useful overview of fluconazole resistance in VVC and covers such topics as:

• Trends in drug resistance in VVC
• How drug resistance happens in VVC
• Dramatic increases in fluconazole dosages
• Guidelines for treating non-albicans VVC
• Special treatment considerations for pregnant and diabetic patients